Core Viewpoint - The HPV vaccine, crucial for preventing cervical cancer in women, is gaining attention in China, with discussions on its inclusion in national immunization programs and local public health initiatives [1][6]. Group 1: Current Policies and Implementation - Sixteen provinces in China have introduced policies for HPV vaccination, with Beijing offering free vaccinations for eligible schoolgirls starting this autumn [2][3]. - The implementation plan in Beijing specifies the use of domestically produced bivalent HPV vaccines for girls aged 9 to 14, following a specific immunization schedule [2]. Group 2: Public Health Impact - HPV infection is responsible for 80-90% of cervical cancer cases, which ranks as the third most common cancer among women aged 15-44 in China [2]. - The call for government-funded vaccinations has been growing, with initiatives already covering over a million eligible girls in Jiangxi province [3]. Group 3: Challenges in Vaccine Accessibility - Economic disparities across regions pose challenges to the expansion of HPV vaccination programs, with approximately 42% of provinces offering free vaccinations [4]. - The average procurement price of HPV vaccines has decreased by 50-70% due to competitive procurement processes, which could enhance accessibility [4][5]. Group 4: Need for National Immunization Inclusion - Experts advocate for the inclusion of the HPV vaccine in the national immunization program to ensure equitable access for all children, regardless of their economic background [6][7]. - The World Health Organization has set a target for 90% vaccination coverage among girls aged 9-14 by 2030, highlighting the urgency for national policy changes [6][7].

无独有偶，国家卫健委副主任、国家疾控局局长沈洪兵在近期举办的2025年疫苗与健康大会上也透 露，国家疾控局准备做一个到2030年的五年规划，逐步缩小国内免疫规划与国际差距，逐步纳入需 要纳入的疫苗。 根据沈洪兵对未来动态调整国家免疫规划的设想：一是新增疫苗的种类。国际普遍共识的、疾病负担 重、成本效益高、疫苗产能满足需求、财政可负担的，要尽快纳入。二是优化现有疫苗免疫程序。根 据流行特点、防控目标变化、疫苗特性等进行优化。三是探索疫苗退出程序。不属于全人群普遍接种 的疫苗，现有疫苗不适应疾病防控需要等情况，也要考虑疫苗退出，或改为储备疫苗。 2025.04. 24 本文字数：2701，阅读时长大约4分钟 作者 | 第一财经 吴斯旻 我国国家免疫规划已有17年没有纳入新疫苗。时值"世界免疫周"，国家疾控局近日频频发声，释放 出国家免疫规划策略将"动态调整""提质扩容"的信号。多名受访业界人士认为，国家免疫规划疫苗扩 容优化已至关键节点。 国家疾控局卫生免疫司副司长李筱翠近日在国家疾控局召开的一场新闻发布会上介绍说，当前，传染 病仍然是全球面临的公共卫生风险，需要我们不断加强疫苗接种的普及和推广。为此，在当前和今 ...